Business
Pfizer raises 2021 COVID-19 vaccine sales forecast to $45.7 billion – ABC News
Drug manufacturer Pfizer is expected to gain $45.7 billion in sales this year as countries stock up on COVID-19 vaccines.
Pfizer has raised its full-year sales forecast for the COVID-19 vaccine it developed with Germany’s BioNTech by 29 per cent to $US33.5 billion ($45.7 billion), as nations stock up on doses for the rest of the year.
Key points:
- There’s been general positive…
Continue Reading
-
Noosa News23 hours agoGyrocopter pilot injured in crash-landing on K’Gari, north of Brisbane
-
Noosa News14 hours agoRevealed: 75 Qld suburbs you could afford to buy in if lending standards drop
-
General8 hours agoFarmers develop ‘autofill’ tech so agricultural robots can operate around the clock
-
General20 hours agoLiberals offer help to start-ups and set goal for small business growth